⚡️ What’s new in healthcare this week?

A curated list of every week's most relevant links on Digital Health News, hand-picked for you by Light-it.

Beacon Biosignals applies EEG and AI to make brain data easier to capture and interpret in clinical research. Its FDA-cleared headband allows participants to record reliable neurological and sleep data from home, removing the need for lab-based studies. Beacon’s models then convert these signals into validated brain biomarkers, giving research teams earlier and more precise insight into how a therapy is performing. They recently raised $86M in Series B funding.

---

Hey there, Insider! 👋🏼
Hope your week’s been kind to you so far. We’re dropping in this Thursday with a fresh roundup of what’s shaping digital healthcare right now.

Here’s what’s worth your attention this week 👇🏼

1. 8 health systems restore telehealth access after shutdown.

2. Chutes & Ladders: Former FDA official to lead policy at Hims & Hers; ATA CEO to retire in December.

3. GoodRx launches $199 Ozempic and Wegovy pricing, unveils telemedicine for GLP-1 access.

4. Withings Receives FDA clearance for BeamO, an At-home device combining ECG, stethoscope, and thermometer.

5. Distalmotion raises $150M to commercialize surgical robot.

6. Elon Musk says Tesla robot will perform ‘superhuman’ surgeries.

7. Clue adds eight wearable integrations to expand cycle-tracking data.

8. Function Health hits $2.5B valuation with $298M Series B.

9. 10 big themes for AI in healthcare heading into 2026.

10. Arbiter emerges from Stealth with $52M Funding to end healthcare fragmentation with AI.

11. December 3-4, 2025 | Barcelona Spain.
    Health Tech Forward 2025.

Until next week, stay connected!

Digital Health Insider.